ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations

Zhao, Ming*; Guo, Zhi; Zou, Ying-Hua; Li, Xiao; Yan, Zhi-Ping; Chen, Min-Shan; Fan, Wei-Jun; Li, Hai-Liang; Yang, Ji-Jin; Chen, Xiao-Ming; Xu, Lin-Feng; Zhang, Yue-Wei; Zhu, Kang-Shun; Sun, Jun-Hui; Li, Jia-Ping; Jin, Yong; Yu, Hai-Peng; Duan, Feng; Xiong, Bin; Yin, Guo-Wen; Lin, Hai-Lan; Ma, Yi-Long; Wang, Hua-Ming; Gu, Shan-Zhi; Si, Tong-Guo; Wang, Xiao-Dong; Zhao, Chang; Yu, Wen-Chang; Guo, Jian-Hai; Zhai, Jian; Huang, Yong-Hui; Wang, Wei-Yu; Lin, Hai-Feng; Gu, Yang-Kui佛山市第一人民医院; 复旦大学; 广东省人民医院; 广州医学院; 北京大学; 南方医科大学; 清华大学; 上海交通大学; 海南医学院; 浙江大学; 郑州大学; 苏州大学; 中国医学科学院; 中山大学; 中国医学科学院北京协和医院; 1; 5
Hepatology International2023-10-21DOI: 10.1007/s12072-023-10599-6
1被引8阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is one of the most common malignancies and the third leading cause of cancer-related deaths globally. Hepatic arterial infusion chemotherapy (HAIC) treatment is widely accepted as one of the alternative therapeutic modalities for HCC owing to its local control effect and low systemic toxicity. Nevertheless, although accumulating high-quality evidence has displayed the superior survival advantages of HAIC of oxaliplatin, fluorouracil, and leucovorin (HAIC-FOLFOX) compared with standard first-line treatment in different scenarios, the lack of standardization for HAIC procedure and remained controversy limited the proper and safe performance of HAIC treatment in HCC. Therefore, an expert consensus conference was held on March 2023 in Guangzhou, China to review current practices regarding HAIC treatment in patients with HCC and develop widely accepted statements and recommendations. In this article, the latest evidence of HAIC was systematically summarized and the final 22 expert recommendations were proposed, which incorporate the assessment of candidates for HAIC treatment, procedural technique details, therapeutic outcomes, the HAIC-related complications and corresponding treatments, and therapeutic scheme management.

学科与关键词

关键词
Hepatocellular carcinomaHepatic arterial infusion chemotherapyConsensusFOLFOX
相关
加载中…
  • Hepatic arterial infusion chemotherapy with oxaliplatin plus raltitrexed versus oxaliplatin plus fluorouracil in intermediate and advanced hepatocellular carcinoma: A retrospective study.
    Zang, Mengya; Li, Qi; Hu, Xiaoyun; Yuan, Guosheng; Li, Rong; Guo, Yabing; Chen, JinzhangAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 1
  • Neoadjuvant hepatic arterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: A multi-center, phase 3, randomized, controlled clinical trial
    Wei, Wei; Li, Shaohua; Zhao, Rongce; Cheng, Yuan; Li, Qiang; Lu, Lianghe; Mei, Jie; Shang, Changzhen; Luo, Rui; Pan, Mingxin; Xiang, Bangde; Jiang, Yuchuan; Lei, Qiucheng; Cao, Mingrong; Li, Ji-Bin; Zheng, Lie; Chen, Huanwei; Zhong, Jian-Hong; Zhong, Chong; Guo, RongpingAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.被引 2
  • Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)
    Yang, Yu; Sun, Juxian; Wu, Mengchao; Lau, Wan Yee; Zheng, Shusen; Wang, Xue-Hao; Chen, Xiaoping; Fan, Jia; Dong, Jiahong; Cai, Jianqiang; Chen, Minshan; Chen, Yongjun; Cheng, Zhangjun; Dai, Chaoliu; Shan, Jianzhen; Du, Cheng-You; Fang, Chihua; Hu, Heping; Ji, Zhili; Jia, Weidong; Li, Gong; Li, Jing; Li, Jiangtao; Liu, Chang; Liu, Fubao; Ma, Yong; Mao, Yilei; Niu, Zuoxing; Shen, Jie; Shi, Jie; Shi, Xuetao; Song, Wenjie; Sun, Hui-Chuan; Tan, Guang; Tao, Ran; Wang, Xiaohu; Wen, Tianfu; Wu, LiqunLiver Cancer, 2022, 11(6): 511-526.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Hepatology International
发表日期
2023-10-21
DOI
10.1007/s12072-023-10599-6
语言
ENGLISH
成果收录
SCIE
资助标注
No.

作者

  • Z

    Zhao, Ming (通讯) (第一作者)

    sun yat sen univ

  • G

    Guo, Zhi

    tianjin med univ

查看全部 39 位作者收起作者
  • Z

    Zou, Ying-Hua

    peking univ

  • L

    Li, Xiao

    chinese acad med sci · peking union med coll

  • Y

    Yan, Zhi-Ping

    fudan univ

  • C

    Chen, Min-Shan

    sun yat sen univ

  • F

    Fan, Wei-Jun

    sun yat sen univ

  • L

    Li, Hai-Liang

    zhengzhou univ

  • Y

    Yang, Ji-Jin

    second mil med univ

  • C

    Chen, Xiao-Ming

    guangdong gen hosp

  • X

    Xu, Lin-Feng

    sun yat sen univ

  • Z

    Zhang, Yue-Wei

    tsinghua univ

  • Z

    Zhu, Kang-Shun

    2 · guangzhou med univ

  • S

    Sun, Jun-Hui

    1 · zhejiang univ

  • L

    Li, Jia-Ping

    1 · sun yat sen univ

  • J

    Jin, Yong

    2 · soochow univ

  • Y

    Yu, Hai-Peng

    tianjin med univ

  • D

    Duan, Feng

  • X

    Xiong, Bin

    2 · guangzhou med univ

  • Y

    Yin, Guo-Wen

    nanjing med univ · jiangsu inst canc res

  • L

    Lin, Hai-Lan

  • M

    Ma, Yi-Long

    guangxi med univ

  • W

    Wang, Hua-Ming

    5 · chinese peoples liberat army gen hosp

  • G

    Gu, Shan-Zhi

    hunan canc hosp

  • S

    Si, Tong-Guo

    tianjin med univ

  • W

    Wang, Xiao-Dong

    peking univ canc hosp & inst

  • Z

    Zhao, Chang

    guangxi med univ

  • Y

    Yu, Wen-Chang

    fujian canc hosp · fujian med univ

  • G

    Guo, Jian-Hai

    peking univ canc hosp & inst

  • Z

    Zhai, Jian

  • H

    Huang, Yong-Hui

    1 · sun yat sen univ

  • W

    Wang, Wei-Yu

    shanghai jiao tong univ

  • L

    Lin, Hai-Feng

  • G

    Gu, Yang-Kui

    sun yat sen univ

  • C

    Chen, Jin-Zhang

    southern med univ

  • W

    Wang, Jian-Peng

    peoples hosp foshan 1 · sun yat sen univ

  • Z

    Zhang, Yi-Min

    sun yat sen univ

  • Y

    Yi, Jun-Zhe

    sun yat sen univ

  • L

    Lyu, Ning

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417